SCPH insider transaction filings
scPharmaceuticals Inc. — 39 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-10-07. Screen SCPH transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for SCPH between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — scPharmaceuticals Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-07 | 4 | Abraham William Tober — Director | Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Baylor-Henry Minnie — Director | Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 · Disposition to issuer (D): 6,124 (derivative) @ $0 · Disposition to issuer (D): 12,248 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Nokes Rachael — CFO and Treasurer | Code (U): 30,386 · Disposition to issuer (D): 125,675 · Disposition to issuer (D): 132,670 (derivative) @ $0 · Disposition to issuer (D): 54,700 (derivative) @ $0 · Disposition to issuer (D): 6,426 (derivative) @ $0 · Disposition to issuer (D): 13,850 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Agger Mette Kirstine — Director | Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Bonstein Sara — Director | Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Khattar Jack A. — Director | Code (U): 5,000 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 · Disposition to issuer (D): 6,124 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Hudson Frederick M. — Director | Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 · Disposition to issuer (D): 6,124 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | Tucker John H — President and CEO, Director | Code (U): 122,345 · Disposition to issuer (D): 318,502 · Disposition to issuer (D): 300,000 (derivative) @ $0 · Disposition to issuer (D): 84,500 (derivative) @ $0 · Disposition to issuer (D): 249,000 (derivative) @ $0 · Disposition to issuer (D): 496,674 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | VEITINGER KLAUS R DR — Director | Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 · Disposition to issuer (D): 6,124 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | SCHAEFFER LEONARD D — Director | Code (U): 68,796 · Code (U): 43,104 · Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Agger Mette Kirstine — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Baylor-Henry Minnie — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Abraham William Tober — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Bonstein Sara — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Khattar Jack A. — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Hudson Frederick M. — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | VEITINGER KLAUS R DR — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | SCHAEFFER LEONARD D — Director | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Nokes Rachael — CFO and Treasurer | Grant/award (A): 88,445 @ $0 · Grant/award (A): 132,670 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Tucker John H — President and CEO, Director | Grant/award (A): 200,000 @ $0 · Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | Nokes Rachael — CFO and Treasurer | Tax withholding (F): 5,235 @ $3.56 | EDGAR |
| 2025-01-07 | 4 | Tucker John H — President and CEO, Director | Tax withholding (F): 13,360 @ $3.56 | EDGAR |
| 2024-08-28 | 4/A | Nokes Rachael — CFO and Treasurer | Option exercise (M): 10,445 @ $1.66 | EDGAR |
| 2024-08-28 | 4 | SCHAEFFER LEONARD D — Director | Option exercise (M): 5,223 @ $1.66 · Option exercise (M): 6,124 @ $3.37 · Option exercise (M): 5,223 (derivative) @ $0 · Option exercise (M): 6,124 (derivative) @ $0 | EDGAR |
| 2024-08-15 | 4 | ORBIMED ADVISORS LLC — 10% owner OrbiMed Capital GP VI LLC — 10% owner OrbiMed Genesis GP LLC — 10% owner | Purchase (P): 478,342 @ $4 · Purchase (P): 21,658 @ $4 | EDGAR |
| 2024-08-08 | 4 | Nokes Rachael — CFO and Treasurer | Option exercise (M): 10,445 @ $0 · Option exercise (M): 10,445 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Agger Mette Kirstine — Director | Grant/award (A): 19,750 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Abraham William Tober — Director | Grant/award (A): 19,750 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Baylor-Henry Minnie — Director | Grant/award (A): 19,750 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Bonstein Sara — Director | Grant/award (A): 19,750 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Khattar Jack A. — Director | Grant/award (A): 19,750 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Hudson Frederick M. — Director | Grant/award (A): 19,750 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | VEITINGER KLAUS R DR — Director | Grant/award (A): 19,750 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | SCHAEFFER LEONARD D — Director | Grant/award (A): 19,750 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | Tucker John H — President and CEO, Director | Grant/award (A): 56,025 (derivative) @ $0 | EDGAR |
| 2024-01-22 | 4 | Nokes Rachael — CFO and Treasurer | Grant/award (A): 41,840 @ $0 · Grant/award (A): 62,755 (derivative) @ $0 | EDGAR |
| 2024-01-22 | 4 | Tucker John H — President and CEO, Director | Grant/award (A): 113,560 @ $0 · Grant/award (A): 170,340 (derivative) @ $0 | EDGAR |
| 2024-01-03 | 4 | Nokes Rachael — CFO and Treasurer | Tax withholding (F): 1,027 @ $6.39 | EDGAR |
| 2024-01-03 | 4 | Tucker John H — President and CEO, Director | Tax withholding (F): 4,942 @ $6.39 | EDGAR |
Recent 8-K events — scPharmaceuticals Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-10-07 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-09 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-19 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-10 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-11 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SCPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →